← Browse by Condition
Medical Condition

membranous nephropathy pla2r induced

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2, Phase 3
NCT07163611 Phase 2, Phase 3
Recruiting

Obinutuzumab Induced Decreases of PLA2R Antibodies in Membranous Nephropathy: a Pilot Study

Enrollment
20 pts
Location
Netherlands
Sponsor
Radboud University Medical Cen...
View Trial →